A Pivotal Phase 2b/3, Multicentre, Randomised, Open, Controlled Study on the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB) Implantation in Non-Infected Hypotrophic Non-Union Fractures

Trial Profile

A Pivotal Phase 2b/3, Multicentre, Randomised, Open, Controlled Study on the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB) Implantation in Non-Infected Hypotrophic Non-Union Fractures

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 22 Oct 2017

At a glance

  • Drugs Autologous osteoblastic cell therapy Bone Therapeutics (Primary)
  • Indications Non-union fracture
  • Focus Therapeutic Use
  • Sponsors Bone Therapeutics
  • Most Recent Events

    • 16 Oct 2017 Planned End Date changed from 1 Jun 2017 to 1 Apr 2018.
    • 16 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Apr 2018.
    • 16 Oct 2017 Status changed from recruiting to discontinued.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top